- Home
- BLKB vs CMPS Comparison
BLKB vs CMPS Comparison
Compare BLKB & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLKB | CMPS |
|---|---|---|
| Founded | 1981 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BLKB | CMPS |
|---|---|---|
| Price | $30.44 | $13.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $50.00 | $25.38 |
| AVG Volume (30 Days) | 892.6K | ★ 3.2M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.32 | N/A |
| EPS | ★ 0.67 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.26 | N/A |
| Revenue Next Year | $4.25 | N/A |
| P/E Ratio | $44.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.58 | $3.25 |
| 52 Week High | $74.86 | $15.40 |
Technical Indicators
Market Signals| Indicator | BLKB | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 55.83 | 57.56 |
| Support Level | $28.88 | $5.57 |
| Resistance Level | $32.93 | $14.76 |
| Average True Range (ATR) | 1.48 | 0.94 |
| MACD | 0.61 | 0.10 |
| Stochastic Oscillator | 86.73 | 57.98 |
Price Performance
Historical ComparisonAbout BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.